Sheldon C. Cooper, Roland C. Aldridge, Tahir Shah, Kerry Webb, Peter Nightingale, Sue Paris, Bridget K. Gunson, David J. Mutimer, James M. Neuberger – 29 September 2009 – Paracetamol (acetaminophen) hepatotoxicity, whether due to intentional overdose or therapeutic misadventure, is an indication for liver transplantation in selected cases. However, there is a concern that long‐term outcomes may be compromised by associated psychopathology that may predispose patients to further episodes of self‐harm or poor treatment adherence.

Albert J. Czaja – 29 September 2009

Mircelal Kazimi, Can Karaca, Mustafa Ozsoy, Murat Ozdemir, Anil Ziya Apaydin, Sezgin Ulukaya, Murat Zeytunlu, Murat Kilic – 29 September 2009

Michael Abecassis – 29 September 2009

Eric Levesque, Faouzi Saliba, Sonia Benhamida, Philippe Ichaï, Daniel Azoulay, René Adam, Denis Castaing, Didier Samuel – 29 September 2009 – Indocyanine green clearance (Cl‐ICG) has been used to assess liver function and hepatic blood flow mainly before and after hepatic surgery. Cl‐ICG (invasive method) has been reported to be a good marker of early graft function after liver transplantation (LT).

Olivier de Rougemont, Kuno Lehmann, Pierre‐Alain Clavien – 29 September 2009 – Ischemia and reperfusion lead to injury of the liver. Ischemia‐reperfusion injury is inevitable in liver transplantation and trauma and, to a great extent, in liver resection. This article gives an overview of the mechanisms involved in this type of injury and summarizes protective and treatment strategies in clinical use today. Intervention is possible at different time points: during harvesting, during the period of preservation, and during implantation.

J. Christie Heller, Allan V. Prochazka, Gregory T. Everson, Lisa M. Forman – 29 September 2009 – As long‐term survival after liver transplantation increases, metabolic complications are becoming increasingly prevalent. Given concerns about which group of providers should be managing liver recipients and how well metabolic complications are managed, we administered a postal survey to 280 transplant hepatologists to determine attitudes, perceptions, and practice patterns in the management of metabolic complications after transplantation. The response rate was 68.2%.

Yu‐Fan Cheng, Hsin‐You Ou, Leo Leung‐Chit Tsang, Chun‐Yen Yu, Tung‐Liang Huang, Tai‐Yi Chen, Allan Concejero, Chee‐Chien Yong, Chao‐Long Chen – 29 September 2009

Nicholas A. Shackel – 29 September 2009

Paula Buchanan, Nino Dzebisashvili, Krista L. Lentine, David A. Axelrod, Mark A. Schnitzler, Paolo R. Salvalaggio – 29 September 2009 – We examined the relationship between the total cost incurred by liver transplantation (LT) recipients and their Model for End‐Stage Liver Disease (MELD) score at the time of transplant. We used a novel database linking billing claims from a large private payer with the Organ Procurement and Transplantation Network registry. Included were adults who underwent LT from March 2002 through August 2007 (n = 990).